Clinical Trials on Dipsogenic Diabetes Insipidus in Russian Federation
Total 398 results
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusChina, Mexico, Korea, Republic of, Russian Federation
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
SanofiCompletedDiabetes Mellitus, Type 2United States, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Spain, Sweden, Argentina, Denmark, Finland, Hungary, Norway, Colombia, Austria, Greece, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Russian Federation
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Australia, Russian Federation, Spain, Mexico, Canada, France, Korea, Republic of
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, France, Guatemala, Italy, Korea, Republic of, Mexico, Poland, Russian Federation
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesIndia, Macedonia, The Former Yugoslav Republic of, Russian Federation, Turkey, Croatia, Australia, Philippines
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Relatives to/Carers of Patients | Healthcare ProfessionalsSpain, Algeria, China, India, Mexico, Russian Federation, Turkey, Germany, Poland, Japan, Netherlands, Italy, Canada, United Kingdom, Denmark, France, United States
-
BayerCompletedDiabetic RetinopathyKorea, Republic of, Russian Federation, Hong Kong, Taiwan, United States, Argentina, Japan, Denmark, Israel, Spain, Sweden, China, Colombia, Italy, Portugal
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2 | Acute Myocardial InfarctionCanada, Croatia, Czech Republic, Germany, Hungary, India, Israel, Lebanon, Poland, Romania, Russian Federation, Slovakia, Slovenia, South Africa, Spain, Turkey, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Czech Republic, Poland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more
-
SanofiCompletedDiabetes Mellitus, Type 2Algeria, Colombia, Egypt, Guatemala, India, Iran, Islamic Republic of, Lebanon, Mexico, Russian Federation, South Africa, Tunisia, Turkey, Ukraine, United Arab Emirates
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of, Russian Federation, Spain, Denmark, Canada, Germany, Ireland, Portugal, Australia, India, Turkey, Netherlands, Sweden, United Kingdom, Finland, Switzerland, Romania, Brazil, Serbia, Taiwan
-
Eli Lilly and CompanyTerminatedDiabetes Mellitus, Type 2Russian Federation, Puerto Rico, Spain, United States, Australia
-
SanofiCompletedSleep Initiation and Maintenance DisordersUnited States, France, Canada, Brazil, Russian Federation, Netherlands, Switzerland, Turkey, Malaysia, Taiwan, Czech Republic, Finland, Italy, Colombia, South Africa, Greece
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Russian Federation, Mexico, Ukraine, Puerto Rico
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Romania, Slovakia, Israel, Saudi Arabia, India, Malaysia, Mexico, Russian Federation, Germany, Croatia, Poland, Serbia, Bulgaria, Canada, Slovenia, Sweden, Denmark, Hungary, Argentina, Austria, Finland, Lebanon, Czechia, Netherlands
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Mannkind CorporationTerminatedType 2 Diabetes Mellitus | Asthma | Type 1 Diabetes Mellitus | Moderate Chronic Obstructive Pulmonary DiseaseUnited States, Russian Federation, Ukraine
-
Boehringer IngelheimCompletedHypertension | Diabetic NephropathiesSpain, Taiwan, Malaysia, Italy, Portugal, France, Czech Republic, Korea, Republic of, Russian Federation, Denmark, Germany, Slovakia, Ukraine
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
Novartis PharmaceuticalsActive, not recruitingProliferative Diabetic RetinopathyChina, India, Japan, Russian Federation, Turkey, Canada, United States, Australia, Korea, Republic of, Brazil, Philippines, Puerto Rico, Taiwan, Argentina, Chile, Mexico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Hong Kong, Spain, United States, Mexico, Russian Federation, Guatemala, United Kingdom, Brazil
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Poland, Czech Republic
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Russian Federation, Puerto Rico, United States, Australia, Hungary, Poland, Romania, Spain
-
Chromaderm, Inc.CompletedDiabetic RetinopathyUnited States, Canada, France, Denmark, Australia, Netherlands, Taiwan, Spain, Italy, Germany, Portugal, United Kingdom, Russian Federation, Poland, India, Brazil, Mexico
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2United States, Russian Federation, Israel, Mexico, Ukraine, Romania
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Russian Federation, Denmark, Sweden, Macedonia, The Former Yugoslav Republic of, Norway, Croatia, France, Belgium, Slovakia
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesGermany, Poland, Russian Federation, Spain, Sweden, Netherlands, Singapore, Malaysia, France, Croatia, Romania, United Kingdom, Hong Kong
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Korea, Republic of, Malaysia, Philippines, Thailand, Russian Federation, Mexico
-
PhenomixForest LaboratoriesTerminatedType 2 Diabetes Mellitus | Renal ImpairmentUnited States, Russian Federation, Ukraine
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Japan, Hungary, Poland, Russian Federation, Bulgaria, Serbia, Greece, Denmark
-
AstraZenecaEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, United Kingdom, Portugal, Spain, Netherlands, Croatia, Slovenia, Greece, Italy, Germany, Romania, Russian Federation
-
SanofiTerminatedSleep Initiation and Maintenance DisordersUnited States, Canada, Brazil, Russian Federation, Australia, Germany, Italy, Spain, Turkey, India, Malaysia, Singapore, Belgium, Czech Republic, Mexico, Argentina, Austria, Colombia, Chile, South Africa, United Kingdom, Hong Kong
-
Sirtris, a GSK CompanyGlaxoSmithKlineCompletedDiabetes Mellitus, Type 2Bulgaria, Estonia, Russian Federation, Ukraine, United Kingdom, Hungary, Poland, Romania
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Russian Federation, Poland, Spain, Mexico, Croatia, Denmark, India
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
BayerCompletedDiabetic Kidney DiseaseBelgium, Finland, France, Spain, China, Hong Kong, Switzerland, United States, Colombia, Turkey, Greece, New Zealand, Poland, Korea, Republic of, Portugal, Taiwan, Japan, Russian Federation, Singapore, Australia, Netherlands, Sweden, Austr... and more
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Netherlands, Russian Federation, India, Belgium, Japan, Romania, Italy
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Canada, Mexico, Philippines, Romania, Russian Federation, Ukraine
-
BayerCompletedDiabetic Foot | Ulcer | Abscess | Wound InfectionItaly, Spain, Greece, Ireland, Russian Federation, United Kingdom, Germany, Austria, Belgium, France, Hungary, South Africa, Romania, Bulgaria, Poland, Israel, Latvia, Ukraine, Lithuania, Netherlands
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Italy, Hong Kong, Romania, Greece, United States, Mexico, Serbia, Russian Federation
-
Lexicon PharmaceuticalsSanofiTerminatedType 2 Diabetes MellitusUnited States, Australia, Canada, Korea, Republic of, Mexico, New Zealand, Russian Federation, Taiwan
-
Eli Lilly and CompanyWithdrawnDiabetes Mellitus, Type 2United States, Spain, Poland, Austria, Germany, Czech Republic, Russian Federation
-
AstraZenecaCompletedType 2 DiabetesUnited States, Puerto Rico, Mexico, Russian Federation, Romania, Poland, Czech Republic, United Kingdom
-
Janssen Research & Development, LLCThe George Institute for Global Health, AustraliaCompletedDiabetes Mellitus, Type 2 | Diabetic NephropathyUnited States, Canada, France, Germany, Poland, Ukraine, United Kingdom, China, Taiwan, Spain, Argentina, Colombia, Mexico, Bulgaria, India, Malaysia, Romania, Serbia, South Africa, Japan, Australia, Korea, Republic of, Chile, New Zealand and more
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Australia, Mexico, Taiwan, United States, Israel, Russian Federation, Slovakia, Ukraine, Guatemala, Peru, Romania
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey